These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25936523)

  • 21. mTORC1 signalling and eIF4E/4E-BP1 translation initiation factor stoichiometry influence recombinant protein productivity from GS-CHOK1 cells.
    Jossé L; Xie J; Proud CG; Smales CM
    Biochem J; 2016 Dec; 473(24):4651-4664. PubMed ID: 27760840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein kinase C and P2Y12 take center stage in thrombin-mediated activation of mammalian target of rapamycin complex 1 in human platelets.
    Moore SF; Hunter RW; Hers I
    J Thromb Haemost; 2014 May; 12(5):748-60. PubMed ID: 24612393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus NS5A binds to the mRNA cap-binding eukaryotic translation initiation 4F (eIF4F) complex and up-regulates host translation initiation machinery through eIF4E-binding protein 1 inactivation.
    George A; Panda S; Kudmulwar D; Chhatbar SP; Nayak SC; Krishnan HH
    J Biol Chem; 2012 Feb; 287(7):5042-58. PubMed ID: 22184107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. mTOR-dependent regulation of PHLPP expression controls the rapamycin sensitivity in cancer cells.
    Liu J; Stevens PD; Gao T
    J Biol Chem; 2011 Feb; 286(8):6510-20. PubMed ID: 21177869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulated in development and DNA damage 1 is necessary for hyperglycemia-induced vascular endothelial growth factor expression in the retina of diabetic rodents.
    Dennis MD; Kimball SR; Fort PE; Jefferson LS
    J Biol Chem; 2015 Feb; 290(6):3865-74. PubMed ID: 25548280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inactivation of the mTORC1-eukaryotic translation initiation factor 4E pathway alters stress granule formation.
    Fournier MJ; Coudert L; Mellaoui S; Adjibade P; Gareau C; Côté MF; Sonenberg N; Gaudreault RC; Mazroui R
    Mol Cell Biol; 2013 Jun; 33(11):2285-301. PubMed ID: 23547259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re-evaluating the roles of proposed modulators of mammalian target of rapamycin complex 1 (mTORC1) signaling.
    Wang X; Fonseca BD; Tang H; Liu R; Elia A; Clemens MJ; Bommer UA; Proud CG
    J Biol Chem; 2008 Nov; 283(45):30482-92. PubMed ID: 18676370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphatidylinositol-3 kinase-dependent translational regulation of Id1 involves the PPM1G phosphatase.
    Xu K; Wang L; Feng W; Feng Y; Shu HK
    Oncogene; 2016 Nov; 35(44):5807-5816. PubMed ID: 27065332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of mTORC1 by SU6656, the selective Src kinase inhibitor, is not accompanied by activation of Akt/PKB signalling in melanoma cells.
    Ondrušová L; Réda J; Záková P; Tuháčková Z
    Folia Biol (Praha); 2013; 59(4):162-7. PubMed ID: 24093774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Point mutations of the mTOR-RHEB pathway in renal cell carcinoma.
    Ghosh AP; Marshall CB; Coric T; Shim EH; Kirkman R; Ballestas ME; Ikura M; Bjornsti MA; Sudarshan S
    Oncotarget; 2015 Jul; 6(20):17895-910. PubMed ID: 26255626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adaptation to mTOR kinase inhibitors by amplification of eIF4E to maintain cap-dependent translation.
    Cope CL; Gilley R; Balmanno K; Sale MJ; Howarth KD; Hampson M; Smith PD; Guichard SM; Cook SJ
    J Cell Sci; 2014 Feb; 127(Pt 4):788-800. PubMed ID: 24363449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylation of eIF4E by MNKs supports protein synthesis, cell cycle progression and proliferation in prostate cancer cells.
    Bianchini A; Loiarro M; Bielli P; Busà R; Paronetto MP; Loreni F; Geremia R; Sette C
    Carcinogenesis; 2008 Dec; 29(12):2279-88. PubMed ID: 18809972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 4E-BPs Control Fat Storage by Regulating the Expression of Egr1 and ATGL.
    Singh M; Shin YK; Yang X; Zehr B; Chakrabarti P; Kandror KV
    J Biol Chem; 2015 Jul; 290(28):17331-8. PubMed ID: 25814662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 4E-BP1, a multifactor regulated multifunctional protein.
    Qin X; Jiang B; Zhang Y
    Cell Cycle; 2016; 15(6):781-6. PubMed ID: 26901143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High prevalence of mTOR complex activity can be targeted using Torin2 in papillary thyroid carcinoma.
    Ahmed M; Hussain AR; Bavi P; Ahmed SO; Al Sobhi SS; Al-Dayel F; Uddin S; Al-Kuraya KS
    Carcinogenesis; 2014 Jul; 35(7):1564-72. PubMed ID: 24583924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms.
    Wilson-Edell KA; Yevtushenko MA; Rothschild DE; Rogers AN; Benz CC
    Breast Cancer Res Treat; 2014 Apr; 144(2):287-298. PubMed ID: 24562770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. mTORC2 is required for proliferation and survival of TSC2-null cells.
    Goncharova EA; Goncharov DA; Li H; Pimtong W; Lu S; Khavin I; Krymskaya VP
    Mol Cell Biol; 2011 Jun; 31(12):2484-98. PubMed ID: 21482669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
    Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J
    PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterozygous inactivation of tsc2 enhances tumorigenesis in p53 mutant zebrafish.
    Kim SH; Kowalski ML; Carson RP; Bridges LR; Ess KC
    Dis Model Mech; 2013 Jul; 6(4):925-33. PubMed ID: 23580196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Focal Adhesion- and IGF1R-Dependent Survival and Migratory Pathways Mediate Tumor Resistance to mTORC1/2 Inhibition.
    Yoon SO; Shin S; Karreth FA; Buel GR; Jedrychowski MP; Plas DR; Dedhar S; Gygi SP; Roux PP; Dephoure N; Blenis J
    Mol Cell; 2017 Aug; 67(3):512-527.e4. PubMed ID: 28757207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.